AI in medicine—a threat to patient autonomy? Medical Xpress Nawigacja wpisu Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsychiatric Disorders through the Advancement of Novel Medicines – Business Wire Two Weill Cornell Medicine Faculty Members Elected to ASCI – Weill Cornell Medicine Newsroom
